Korean J Med.
2020 Jun;95(3):162-169. 10.3904/kjm.2020.95.3.162.
Treatment of Systemic Lupus Erythematosus
- Affiliations
-
- 1Division of Rheumatology, Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
- KMID: 2503141
- DOI: http://doi.org/10.3904/kjm.2020.95.3.162
Abstract
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies that result in the inflammation of multiple organs, including the skin and musculoskeletal, renal, nervous, cardiovascular, respiratory, and gastrointestinal systems. Treatment includes the use of immunomodulatory and immunosuppressive agents to target specific organ manifestations. The treatment goal in SLE is to reduce disease activity and prevent organ damage and death. Optimal long-term outcomes require not only treatment of the disease, but also the management of comorbidities. This paper reviews treatments of SLE with the aim of improving outcomes.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Transverse Myelitis as a First Manifestation of Systemic Lupus Erythematosus
- A Case of Lupus Enteritis That Developed during the Treatment of Systemic Lupus Erythematosus
- A Case Of Systemic Lupus Erythematosus Associated With Hyperthyroidism And Severe Retinopathy
- Multiple Dermatofibromas in a woman with Systemic Lupus Erythematosus
- A Ruptured Aneurysm in a Patient with Systemic Lupus Erythematosus: Case Report
